PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not

Journal of Investigative Dermatology

Volumn 128, Issue 7, 2008, Pages 1757-1762

  LaBerge, Greggory S ^a   Bennett, Dorothy C ^b   Fain, Pamela R ^a,c   Spritz, Richard A ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CTLA4 GENE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MELANOCYTE; PHENOTYPE; PRIORITY JOURNAL; PTPN22 GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

EID: 45349101479     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701233     Document Type: Article

References (50)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002) Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97-101
2. al-Fouzan A, al-Arbash M, Fouad F, Kaaba SA, Mousa MA, al-Harbi SA (1995) Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet 22:209-13
3. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208-14
4. Ando I, Chi HI, Nakagawa H, Otsuka F (1993) Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol 129:408-10
5. Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes J, Jaramillo D et al. (2002) Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet 110:334-42
6. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-5
7. Bhatia PS, Mohan L, Pandey ON, Singh KK, Arora SK, Mukhija RD (1992) Genetic nature of vitiligo. J Dermatol Sci 4:180-4
8. Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE et al. (2005) CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res 18:55-8
9. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36:337-8
10. Brand O, Gough S, Heward J (2005) HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med 7:1-15
11. Canton I, Askar S, Gavalas NG, Gawkrodger DJ, Blomoff A, Watson PF et al. (2005) A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 6:584-7
12. Carnevale A, Zavala C, del Castillo V, Ruiz Maldonado R, Tamayo L (1980) Genetic analysis of 127 families with vitiligo. Rev Invest Clin 32:37-41
13. Cordell HJ, Clayton DG (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70:124-41
14. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M et al. (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561-71
15. Das SK, Majumder PP, Chakraborty R, Majumdar TK, Haldar B (1985a) Studies on vitiligo I. Epidemiological profile in Calcutta, India. Genet Epidemiol 2:71-8
16. Das SK, Majumder PP, Majumdar TK, Haldar B (1985b) Studies on vitiligo II. Familial aggregation and genetics. Genet Epidemiol 2:255-62
17. Fain PR, Babu SR, Bennett DC, Spritz RA (2006) HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 19:51-7
18. Finco O, Cuccia M, Martinetti M, Ruberto G, Orecchia G, Rabbiosi G (1991) Age of onset in vitiligo: relationship with HLA supratypes. Clin Genet 39:48-54
19. Foley LM, Lowe NJ, Misheloff E, Tiwari JL (1983) Association of HLA-DR4 with vitiligo. J Am Acad Dermatol 8:39-40
20. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. (2002) The structure of haplotype blocks in the human genome. Science 296:2225-9
21. Gregersen PK, Lee H-S, Batliwalla F, Begovich AB (2006) PTPN22: setting thresholds for autoimmunity. Semin Immunol 18:214-23
22. Hafez M, Sharaf L, Abd el-Nabi SM (1983) The genetics of vitiligo. Acta Derm Venereol 63:249-51
23. Hann SK, Nordlund JJ (2000) Vitiligo: a Comprehensive Monograph on Basic and Clinical Science. Oxford: Blackwell Science
24. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61
25. Horvath S, Wei E, Xu X, Palmer LJ, Baur M (2001) Family-based association test method: age of onset traits and covariates. Genet Epidemiol 21(Suppl 1):S403-8
26. Howitz J, Brodthagen H, Schwartz M, Thomsen K (1977) Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 113:47-52
27. Itirli G, Pehlivan M, Alper S, Yuksel SE, Onay H, Ozkinay F et al. (2005) Exon-3 polymorphism of CTLA-4 gene in Turkish patients with vitiligo. J Dermatol Sci 38:225-7
28. Jin Y, Birlea SA, Fain PR, Spritz RA (2007b) Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 127:2558-62
29. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC et al. (2007a) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356:1216-25
30. Kemp EH, Ajjan RA, Waterman EA, Gawkrodger DJ, Cork MJ, Watson PF et al. (1999) Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with Vitiligo. Br J Dermatol 140:73-8
31. LaBerge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR et al. (2005) Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18:300-5
32. Liu JB, Li M, Chen H, Zhong SQ, Yang S, Du WD et al. (2007) Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 21:205-13
33. Lu T, Gao T, Wang A, Jin Y, Li Q, Li C (2007) Vitiligo prevalence study in Shaanxi Province, China. Int J Dermatol 46:47-51
34. Majumder PP, Das SK, Li CC (1988) A genetical model for vitiligo. Am J Hum Genet 43:119-25
35. Majumder PP, Nordlund JJ, Nath SK (1993) Pattern of familial aggregation of vitiligo. Arch Dermatol 129:994-8
36. Mehta NR, Shah KC, Theodore C, Vyas VP, Patel AB (1973) Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J Med Res 61:145-54
37. Nath SK, Majumder PP, Nordlund JJ (1994) Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 55:981-90
38. Nistor I, Nair RP, Stuart P, Hiremagalore R, Thompson RA, Jenisch S et al. (2005) Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association. J Invest Dermatol 125:395-6
39. Nordlund JJ, Ortonne J-P, LePoole IC (2006) Vitiligo vulgaris. In: The Pigmentary System (Nordlund JJ, Boissy RE, Hearing VJ, King, RA, Oetting, WS, Ortonne J-P, eds), 2nd ed. Malden, MA: Blackwell Publishing, 551-98
40. O'Connell JR, Weeks DE (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-66
41. Orecchia G, Perfetti L, Malagoli P, Borghini F, Kipervarg Y (1992) Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in northern Italian patients. Dermatology 185:123-7
42. Schallreuter KU, Levenig C, Kuhnl P, Loliger C, Hohl-Tehari M, Berger J (1993) Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany. Dermatology 187:186-92
43. Siminovitch KA (2004) PTPN22 and autoimmune disease. Nat Genet 36:1248-9
44. Spritz RA (2007) The genetics of generalized vitiligo and associated autoimmune disease. Pigment Cell Res 20:271-8
45. Sun X, Xu A, Wei X, Ouyang J, Lu L, Chen M et al. (2006) Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China. Int J Dermatol 45:1176-81
46. Taïeb A, Picardo M, VETF Members (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27-35
47. Tastan HB, Akar A, Orkunoglu FE, Arca E, Inal A (2004) Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 17:181-4
48. Xia Q, Zhou WM, Liang YH, Ge HS, Liu HS, Wang JY et al. (2006) MHC haplotypic association in Chinese Han patients with vitiligo. J Eur Acad Dermatol Venereol 20:941-6
49. Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, Nieuweboer-Krobotova L et al. (2001) Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 145:90-4
50. Zhernakova A, Eerligh P, Wijmenga C, Barrera P, Roep BO, Koeleman BP (2005) Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun 6:459-61